Jennifer Payne, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    SAGE Therapeutics
    Topic:
    Zuranolone
    Date added:
    01/27/2025
    Date updated:
    01/27/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Biogen
    Topic:
    Zuranolone
    Date added:
    01/27/2025
    Date updated:
    01/27/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Reunion
    Topic:
    Postpartum Depression
    Date added:
    01/27/2025
    Date updated:
    01/27/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Brii Biologics
    Topic:
    Postpartum Depression
    Date added:
    01/27/2025
    Date updated:
    01/27/2025
    Relationship end date:
    07/19/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Dionysus health
    Topic:
    Epigenetic Biomarkers of PPD
    Date added:
    01/27/2025
    Date updated:
    01/27/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Flo Health
    Topic:
    Premenstrual, perimenopausal symptoms
    Date added:
    01/27/2025
    Date updated:
    01/27/2025
  • Attribution:
    Self
    Type of financial relationship:
    Contracted Research
    Ineligible company:
    Jannsen
    Topic:
    Treatment Resistant Depression
    Date added:
    01/27/2025
    Date updated:
    01/27/2025
    Relationship end date:
    12/12/2024
  • Attribution:
    Self
    Type of financial relationship:
    Contracted Research
    Ineligible company:
    Myriad Genetics
    Topic:
    Pharmacokinetics after pregnancy
    Date added:
    01/27/2025
    Date updated:
    01/27/2025
Return to 2025 Inova Department of Psychiatry Grand Rounds